Dallas, TX, March 27, 2016 --(PR.com
)-- Body composition analyzers are used to determine different parameters of body composition, including body fat percentage, total body water, bioelectrical impedance, land body weight, and body mass index, among others. Recent innovations in this category include segmental analysis (lean body mass of arm, leg and trunk), which help to differentiate between fat and muscle in each limb.
The global body composition analyzers market is accounted for revenue of $1031.2 million in 2015, growing at a CAGR of 9.1% from 2016 to 2022. This market is steadily progressing, driven by various factors, such as rise in obese population, growing health and fitness consciousness, government initiatives for public health awareness, and increasing health club memberships.
The main products covered in the report are Bioelectrical Impedance Analyzers (BIA), Hydrostatic Weighing (HwD), Dual Energy X-ray Absorptiometry (DEXA), Air Displacement Plethysmography (ADP), skinfold calipers, and others. On the basis of geography, the global body composition analyzer market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Bioimpedance Analysis (BIA), also known as bioelectrical impedance analysis, is a method used to measure body composition, which implies the measurement of body fat in relation to lean body mass. BIA is considered to be an integral part of health and nutrition assessment. Bioelectrical impedance analysis is especially used for its high speed information processing. It is a noninvasive method that is easy to use and requires relatively inexpensive equipment. It estimates the distribution of body fluids in the intra and intercellular spaces in addition to the body components. Bioelectrical impedance analyzers are used in private clinics, offices, health clubs, hospitals, and across a spectrum of ages, body weights, and disease states. Despite a general public perception that BIA measures body fat, the technology also determines the electrical impedance of body tissues, which provides an estimate of Total Body Water (TBW). Using the estimated values of TBW derived from BIA, Fat-Free Mass (FFM) and body fat (adiposity) can be estimated. In addition to its use in estimating adiposity, BIA is also used in the estimation of body cell mass and TBW in a variety of clinical conditions. The BIA market accounted for the largest share of 42.1% of the global body composition analyzers market in 2015. The BIA segment was valued at $434.2 million in 2015 and is projected to reach $948.0 million by 2022, at a CAGR of 11.6% from 2016 to 2022.
North America accounted for the largest share of the global market revenues in 2015, owing to the rising obese population, along with the technologically-advanced healthcare infrastructure in the region. The Asia-Pacific region is expected to witness significant growth in the coming years as a result of the increasing awareness regarding healthcare, especially in emerging economies such as India and China.
The major players profiled in the in the global body composition analyzers market report includes Tanita (Japan), InBody Co., Ltd. (South Korea), Omron Healthcare, Inc. (Japan), Jawon Medical Co., Ltd. (Korea), Bodystat (U.K.), Hologic, Inc. (U.S.), GE Healthcare (U.K.), COSMED (Italy), Beurer GmbH (Germany), and Seca (Germany), among others.
For free sample of the report